Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2016 (2016), Article ID 8607038, 13 pages
http://dx.doi.org/10.1155/2016/8607038
Review Article

Plasticity of Hippocampal Excitatory-Inhibitory Balance: Missing the Synaptic Control in the Epileptic Brain

1Centro de Neurobiología y Plasticidad Cerebral (CNPC), Instituto de Fisiología, Facultad de Ciencias, Universidad de Valparaíso, Gran Bretaña Avenida 1111, 2360102 Valparaíso, Chile
2Núcleo Milenio en Biología de Enfermedades Neurosiquiátricas, Instituto de Fisiología, Facultad de Ciencias, Universidad de Valparaíso, Gran Bretaña Avenida 1111, 2360102 Valparaíso, Chile

Received 30 October 2015; Revised 20 January 2016; Accepted 31 January 2016

Academic Editor: Long-Jun Wu

Copyright © 2016 Christian Bonansco and Marco Fuenzalida. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Gastaut, “Letter: Epileptic seizures,” Developmental Medicine and Child Neurology, vol. 15, no. 5, pp. 688–689, 1973. View at Google Scholar · View at Scopus
  2. N. Moghim and D. W. Corne, “Predicting epileptic seizures in advance,” PLoS ONE, vol. 9, no. 6, Article ID e99334, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. B. S. Meldrum, “Excitatory amino acids in epilepsy and potential novel therapies,” Epilepsy Research, vol. 12, no. 2, pp. 189–196, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. R. M. Guerriero, C. C. Giza, and A. Rotenberg, “Glutamate and GABA imbalance following traumatic brain injury,” Current Neurology and Neuroscience Reports, vol. 15, no. 5, article 27, 2015. View at Publisher · View at Google Scholar
  5. K. Chen, I. Aradi, N. Thon, M. Eghbal-Ahmadi, T. Z. Baram, and I. Soltesz, “Persistently modified h-channels after complex febrile seizures convert the seizure-induced enhancement of inhibition to hyperexcitability,” Nature Medicine, vol. 7, no. 3, pp. 331–337, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Khazipov, G. Valeeva, and I. Khalilov, “Depolarizing GABA and developmental epilepsies,” CNS Neuroscience and Therapeutics, vol. 21, no. 2, pp. 83–91, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Kwan, H. M. Li, E. Al-Jufairi et al., “Association between temporal lobe P-glycoprotein expression and seizure recurrence after surgery for pharmacoresistant temporal lobe epilepsy,” Neurobiology of Disease, vol. 39, no. 2, pp. 192–197, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. J. O. McNamara, Y. Z. Huang, and A. S. Leonard, “Molecular signaling mechanisms underlying epileptogenesis,” Science’s STKE, vol. 2006, no. 356, p. re12, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Morimoto, M. Fahnestock, and R. J. Racine, “Kindling and status epilepticus models of epilepsy: rewiring the brain,” Progress in Neurobiology, vol. 73, no. 1, pp. 1–60, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. D. F. Weaver, “Epileptogenesis, ictogenesis and the design of future antiepileptic drugs,” Canadian Journal of Neurological Sciences, vol. 30, no. 1, pp. 4–7, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. H. E. Scharfman, “The neurobiology of epilepsy,” Current Neurology and Neuroscience Reports, vol. 7, no. 4, pp. 348–354, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. D. N. Bowser and B. S. Khakh, “ATP excites interneurons and astrocytes to increase synaptic inhibition in neuronal networks,” The Journal of Neuroscience, vol. 24, no. 39, pp. 8606–8620, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Bonansco, A. Couve, G. Perea, C. Á. Ferradas, M. Roncagliolo, and M. Fuenzalida, “Glutamate released spontaneously from astrocytes sets the threshold for synaptic plasticity,” European Journal of Neuroscience, vol. 33, no. 8, pp. 1483–1492, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Henneberger, T. Papouin, S. H. R. Oliet, and D. A. Rusakov, “Long-term potentiation depends on release of D-serine from astrocytes,” Nature, vol. 463, no. 7278, pp. 232–236, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. D. P. Cain, “Long-term potentiation and kindling: how similar are the mechanisms?” Trends in Neurosciences, vol. 12, no. 1, pp. 6–10, 1989. View at Publisher · View at Google Scholar · View at Scopus
  16. K. J. Meador, “The basic science of memory as it applies to epilepsy,” Epilepsia, vol. 48, no. 9, pp. 23–25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. J. C. Morales, C. Álvarez-Ferradas, M. Roncagliolo et al., “A new rapid kindling variant for induction of cortical epileptogenesis in freely moving rats,” Frontiers in Cellular Neuroscience, vol. 8, article 200, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. R. J. Racine, “Modification of seizure activity by electrical stimulation. II. Motor seizure,” Electroencephalography and Clinical Neurophysiology, vol. 32, no. 3, pp. 281–294, 1972. View at Publisher · View at Google Scholar
  19. G. V. Goddard, D. C. McIntyre, and C. K. Leech, “A permanent change in brain function resulting from daily electrical stimulation,” Experimental Neurology, vol. 25, no. 3, pp. 295–330, 1969. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Dhir, “Pentylenetetrazol (PTZ) kindling model of epilepsy,” Current Protocols in Neuroscience, vol. 1, no. 58, pp. 1–12, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. S. F. Stasheff, A. C. Bragdon, and W. A. Wilson, “Induction of epileptiform activity in hippocampal slices by trains of electrical stimuli,” Brain Research, vol. 344, no. 2, pp. 296–302, 1985. View at Publisher · View at Google Scholar · View at Scopus
  22. S. F. Stasheff, W. W. Anderson, S. Clark, and W. A. Wilson, “NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model,” Science, vol. 245, no. 4918, pp. 648–651, 1989. View at Publisher · View at Google Scholar · View at Scopus
  23. N. T. Slater, A. Stelzer, and M. Galvan, “Kindling-like stimulus patterns induce epileptiform discharges in the guinea pig in vitro hippocampus,” Neuroscience Letters, vol. 60, no. 1, pp. 25–31, 1985. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Mazzuferi, G. Kumar, C. Rospo, and R. M. Kaminski, “Rapid epileptogenesis in the mouse pilocarpine model: video-EEG, pharmacokinetic and histopathological characterization,” Experimental Neurology, vol. 238, no. 2, pp. 156–167, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Dhir, “UNIT 9.37 Pentylenetetrazol (PTZ) kindling model of epilepsy,” in Current Protocols in Neuroscience, chapter 9, John Wiley & Sons, Hoboken, NJ, USA, 2012. View at Publisher · View at Google Scholar
  26. C. P. Taylor and F. E. Dudek, “Synchronous neural afterdischarges in rat hippocampal slices without active chemical synapses,” Science, vol. 218, no. 4574, pp. 810–812, 1982. View at Publisher · View at Google Scholar · View at Scopus
  27. R. C. Malenka and M. F. Bear, “LTP and LTD: an embarrassment of riches,” Neuron, vol. 44, no. 1, pp. 5–21, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Chevaleyre and P. E. Castillo, “Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability,” Neuron, vol. 38, no. 3, pp. 461–472, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Ahumada, D. Fernández de Sevilla, A. Couve, W. Buño, and M. Fuenzalida, “Long-term depression of inhibitory synaptic transmission induced by spike-timing dependent plasticity requires coactivation of endocannabinoid and muscarinic receptors,” Hippocampus, vol. 23, no. 12, pp. 1439–1452, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. R. C. Malenka, “The long-term potential of LTP,” Nature Reviews Neuroscience, vol. 4, no. 11, pp. 923–926, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. G. V. Goddard, “Development of epileptic seizures through brain stimulation at low intensity,” Nature, vol. 214, no. 5092, pp. 1020–1021, 1967. View at Publisher · View at Google Scholar · View at Scopus
  32. M. W. Lopes, F. M. S. Soares, N. De Mello et al., “Time-dependent modulation of AMPA receptor phosphorylation and mRNA expression of NMDA receptors and glial glutamate transporters in the rat hippocampus and cerebral cortex in a pilocarpine model of epilepsy,” Experimental Brain Research, vol. 226, no. 2, pp. 153–163, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Schubert, H. Siegmund, H.-C. Pape, and D. Albrecht, “Kindling-induced changes in plasticity of the rat amygdala and hippocampus,” Learning and Memory, vol. 12, no. 5, pp. 520–526, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Zhu, Y. Liu, Y. Wang, X. Bi, and M. Baudry, “Different patterns of electrical activity lead to long-term potentiation by activating different intracellular pathways,” Journal of Neuroscience, vol. 35, no. 2, pp. 621–633, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. D. E. Naylor, H. Liu, J. Niquet, and C. G. Wasterlain, “Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus,” Neurobiology of Disease, vol. 54, pp. 225–238, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. G. W. Mathern, J. K. Pretorius, J. P. Leite et al., “Hippocampal AMPA and NMDA mRNA levels and subunit immunoreactivity in human temporal lobe epilepsy patients and a rodent model of chronic mesial limbic epilepsy,” Epilepsy Research, vol. 32, no. 1-2, pp. 154–171, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Stief, W. Zuschratter, K. Hartmann, D. Schmitz, and A. Draguhn, “Enhanced synaptic excitation-inhibition ratio in hippocampal interneurons of rats with temporal lobe epilepsy,” European Journal of Neuroscience, vol. 25, no. 2, pp. 519–528, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. C. J. Landmark, “Targets for antiepileptic drugs in the synapse,” Medical Science Monitor, vol. 13, no. 1, pp. RA1–RA7, 2007. View at Google Scholar · View at Scopus
  39. Y. Sugaya, E. Maru, K. Kudo, T. Shibasaki, and N. Kato, “Levetiracetam suppresses development of spontaneous EEG seizures and aberrant neurogenesis following kainate-induced status epilepticus,” Brain Research, vol. 1352, pp. 187–199, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. I. Cavus, W. S. Kasoff, M. P. Cassaday et al., “Extracellular metabolites in the cortex and hippocampus of epileptic patients,” Annals of Neurology, vol. 57, no. 2, pp. 226–235, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Eid, M. J. Thomas, D. D. Spencer et al., “Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy,” The Lancet, vol. 363, no. 9402, pp. 28–37, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Steffens, H.-J. Huppertz, J. Zentner, E. Chauzit, and T. J. Feuerstein, “Unchanged glutamine synthetase activity and increased NMDA receptor density in epileptic human neocortex: implications for the pathophysiology of epilepsy,” Neurochemistry International, vol. 47, no. 6, pp. 379–384, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. W. B. Rowe and A. Meister, “Identification of L-methionine-S-sulfoximine as the convulsant isomer of methionine sulfoximine,” Proceedings of the National Academy of Sciences of the United States of America, vol. 66, no. 2, pp. 500–506, 1970. View at Publisher · View at Google Scholar · View at Scopus
  44. K. P. Lehre and N. C. Danbolt, “The number of glutamate transporter subtype molecules at glutamatergic synapses: chemical and stereological quantification in young adult rat brain,” The Journal of Neuroscience, vol. 18, no. 21, pp. 8751–8757, 1998. View at Google Scholar
  45. K. Tanaka, K. Watase, T. Manabe et al., “Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1,” Science, vol. 276, no. 5319, pp. 1699–1702, 1997. View at Publisher · View at Google Scholar · View at Scopus
  46. E. A. Proper, G. Hoogland, S. M. Kappen et al., “Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy,” Brain, vol. 125, no. 1, pp. 32–43, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. I. Cohen, V. Navarro, C. Le Duigou, and R. Miles, “Mesial temporal lobe epilepsy: a pathological replay of developmental mechanisms?” Biology of the Cell, vol. 95, no. 6, pp. 329–333, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. L. P. Bjørnsen, T. Eid, S. Holmseth, N. C. Danbolt, D. D. Spencer, and N. C. de Lanerolle, “Changes in glial glutamate transporters in human epileptogenic hippocampus: inadequate explanation for high extracellular glutamate during seizures,” Neurobiology of Disease, vol. 25, no. 2, pp. 319–330, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Eddleston and L. Mucke, “Molecular profile of reactive astrocytes—implications for their role in neurologic disease,” Neuroscience, vol. 54, no. 1, pp. 15–36, 1993. View at Publisher · View at Google Scholar · View at Scopus
  50. J. P. Pin and R. Duvoisin, “The metabotropic glutamate receptors: structure and functions,” Neuropharmacology, vol. 34, no. 1, pp. 1–26, 1995. View at Publisher · View at Google Scholar · View at Scopus
  51. E. Aronica, E. A. van Vliet, O. A. Mayboroda, D. Troost, F. H. Lopes Da Silva, and J. A. Gorter, “Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy,” European Journal of Neuroscience, vol. 12, no. 7, pp. 2333–2344, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Panatier, J. Vallée, M. Haber, K. K. Murai, J.-C. Lacaille, and R. Robitaille, “Astrocytes are endogenous regulators of basal transmission at central synapses,” Cell, vol. 146, no. 5, pp. 785–798, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. M. De Pittà, V. Volman, H. Berry, and E. Ben-Jacob, “A tale of two stories: astrocyte regulation of synaptic depression and facilitation,” PLoS Computational Biology, vol. 7, no. 12, Article ID e1002293, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Álvarez-Ferradas, J. C. Morales, M. Wellmann et al., “Enhanced astroglial Ca2+ signaling increases excitatory synaptic strength in the epileptic brain,” Glia, vol. 63, no. 9, pp. 1507–1521, 2015. View at Publisher · View at Google Scholar
  55. E. O. Mann and O. Paulsen, “Role of GABAergic inhibition in hippocampal network oscillations,” Trends in Neurosciences, vol. 30, no. 7, pp. 343–349, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. P. E. Castillo, C. Q. Chiu, and R. C. Carroll, “Long-term plasticity at inhibitory synapses,” Current Opinion in Neurobiology, vol. 21, no. 2, pp. 328–338, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Schipper, M. W. Aalbers, K. Rijkers et al., “Tonic GABAA receptors as potential target for the treatment of temporal lobe epilepsy,” Molecular Neurobiology, 2015. View at Publisher · View at Google Scholar
  58. D. E. Feldman, “The spike-timing dependence of plasticity,” Neuron, vol. 75, no. 4, pp. 556–571, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. S. B. Nelson and G. G. Turrigiano, “Strength through diversity,” Neuron, vol. 60, no. 3, pp. 477–482, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. J.-L. Gaiarsa, O. Caillard, and Y. Ben-Ari, “Long-term plasticity at GABAergic and glycinergic synapses: mechanisms and functional significance,” Trends in Neurosciences, vol. 25, no. 11, pp. 564–570, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Vithlani, M. Terunuma, and S. J. Moss, “The dynamic modulation of GABA(A) receptor trafficking and its role in regulating the plasticity of inhibitory synapses,” Physiological Reviews, vol. 91, no. 3, pp. 1009–1022, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. E. Costa, “From GABAA receptor diversity emerges a unified vision of GABAergic inhibition,” Annual Review of Pharmacology and Toxicology, vol. 38, pp. 321–350, 1998. View at Publisher · View at Google Scholar
  63. M. Farrant and Z. Nusser, “Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors,” Nature Reviews Neuroscience, vol. 6, no. 3, pp. 215–229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. W. Sieghart, “Structure, pharmacology, and function of GABAA receptor subtypes,” Advances in Pharmacology, vol. 54, pp. 231–263, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. F. Pouille and M. Scanziani, “Enforcement of temporal fidelity in pyramidal cells by somatic feed-forward inhibition,” Science, vol. 293, no. 5532, pp. 1159–1163, 2001. View at Publisher · View at Google Scholar · View at Scopus
  66. S. G. Brickley and I. Mody, “Extrasynaptic GABAA receptors: their function in the CNS and implications for disease,” Neuron, vol. 73, no. 1, pp. 23–34, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. J. T. Kittler, I. L. Arancibia-Carcamo, and S. J. Moss, “Association of GRIP1 with a GABAA receptor associated protein suggests a role for GRIP1 at inhibitory synapses,” Biochemical Pharmacology, vol. 68, no. 8, pp. 1649–1654, 2004. View at Publisher · View at Google Scholar
  68. T. C. Jacob, S. J. Moss, and R. Jurd, “GABAA receptor trafficking and its role in the dynamic modulation of neuronal inhibition,” Nature Reviews Neuroscience, vol. 9, no. 5, pp. 331–343, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. L. Cuitino, J. A. Godoy, G. G. Farías et al., “Wnt-5a modulates recycling of functional GABAA receptors on hippocampal neurons,” Journal of Neuroscience, vol. 30, no. 25, pp. 8411–8420, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. Z. Nusser, N. Hájost, P. Somogyi, and I. Mody, “Increased number of synaptic GABA(A) receptors underlies potentiation at hippocampal inhibitory synapses,” Nature, vol. 395, no. 6698, pp. 172–177, 1998. View at Publisher · View at Google Scholar · View at Scopus
  71. Z. Nusser, S. Cull-Candy, and M. Farrant, “Differences in synaptic GABAA receptor number underlie variation in GABA mini amplitude,” Neuron, vol. 19, no. 3, pp. 697–709, 1997. View at Publisher · View at Google Scholar · View at Scopus
  72. D. E. Naylor, H. Liu, and C. G. Wasterlain, “Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus,” The Journal of Neuroscience, vol. 25, no. 34, pp. 7724–7733, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. P. Brambilla, J. Perez, F. Barale, G. Schettini, and J. C. Soares, “GABAergic dysfunction in mood disorders,” Molecular Psychiatry, vol. 8, no. 8, pp. 721–737, 2003. View at Publisher · View at Google Scholar · View at Scopus
  74. G. Tunnicliff and E. Malatynska, “Central GABAergic systems and depressive illness,” Neurochemical Research, vol. 28, no. 6, pp. 965–976, 2003. View at Publisher · View at Google Scholar · View at Scopus
  75. F. Loup, F. Picard, Y. Yonekawa, H.-G. Wieser, and J.-M. Fritschy, “Selective changes in GABAA receptor subtypes in white matter neurons of patients with focal epilepsy,” Brain, vol. 132, no. 9, pp. 2449–2463, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. H. P. Goodkin, S. Joshi, Z. Mtchedlishvili, J. Brar, and J. Kapur, “Subunit-specific trafficking of GABAA receptors during status epilepticus,” The Journal of Neuroscience, vol. 28, no. 10, pp. 2527–2538, 2008. View at Publisher · View at Google Scholar
  77. R. Eckel, B. Szulc, M. C. Walker, and J. T. Kittler, “Activation of calcineurin underlies altered trafficking of α2 subunit containing GABAA receptors during prolonged epileptiform activity,” Neuropharmacology, vol. 88, pp. 82–90, 2015. View at Publisher · View at Google Scholar · View at Scopus
  78. J.-S. Qi, J. Yao, C. Fang, B. Luscher, and G. Chen, “Downregulation of tonic GABA currents following epileptogenic stimulation of rat hippocampal cultures,” Journal of Physiology, vol. 577, no. 2, pp. 579–590, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. I. Pavlov and M. C. Walker, “Tonic GABAA receptor-mediated signalling in temporal lobe epilepsy,” Neuropharmacology, vol. 69, pp. 55–61, 2013. View at Publisher · View at Google Scholar · View at Scopus
  80. V. B. Caraiscos, E. M. Elliott, K. E. You-Ten et al., “Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by α5 subunit-containing γ-aminobutyric acid type A receptors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 10, pp. 3662–3667, 2004. View at Publisher · View at Google Scholar · View at Scopus
  81. Y. Sun, Z. Wu, S. Kong et al., “Regulation of epileptiform activity by two distinct subtypes of extrasynaptic GABAA receptors,” Molecular Brain, vol. 6, article 21, 2013. View at Publisher · View at Google Scholar · View at Scopus
  82. J. Glykys and I. Mody, “Hippocampal network hyperactivity after selective reduction of tonic inhibition in GABAA receptor α5 subunit-deficient mice,” Journal of Neurophysiology, vol. 95, no. 5, pp. 2796–2807, 2006. View at Publisher · View at Google Scholar
  83. J. Glykys and I. Mody, “Activation of GABAA receptors: views from outside the synaptic cleft,” Neuron, vol. 56, no. 5, pp. 763–770, 2007. View at Publisher · View at Google Scholar
  84. K. Chen, I. Aradi, V. Santhakumar, and I. Soltesz, “H-channels in epilepsy: new targets for seizure control?” Trends in Pharmacological Sciences, vol. 23, no. 12, pp. 552–557, 2002. View at Publisher · View at Google Scholar · View at Scopus
  85. V. Chevaleyre, K. A. Takahashi, and P. E. Castillo, “Endocannabinoid-mediated synaptic plasticity in the CNS,” Annual Review of Neuroscience, vol. 29, pp. 37–76, 2006. View at Publisher · View at Google Scholar · View at Scopus
  86. A. E. Chávez, C. Q. Chiu, and P. E. Castillo, “TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus,” Nature Neuroscience, vol. 13, no. 12, pp. 1511–1518, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. R. I. Wilson, G. Kunos, and R. A. Nicoll, “Presynaptic specificity of endocannabinoid signaling in the hippocampus,” Neuron, vol. 31, no. 3, pp. 453–462, 2001. View at Publisher · View at Google Scholar · View at Scopus
  88. T. Ohno-Shosaku, J. Shosaku, H. Tsubokawa, and M. Kano, “Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation,” European Journal of Neuroscience, vol. 15, no. 6, pp. 953–961, 2002. View at Publisher · View at Google Scholar · View at Scopus
  89. D. A. Edwards, J. Kim, and B. E. Alger, “Multiple mechanisms of endocannabinoid response initiation in hippocampus,” Journal of Neurophysiology, vol. 95, no. 1, pp. 67–75, 2006. View at Publisher · View at Google Scholar · View at Scopus
  90. V. Chevaleyre, B. D. Heifets, P. S. Kaeser, T. C. Südhof, D. P. Purpura, and P. E. Castillo, “Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1α,” Neuron, vol. 54, no. 5, pp. 801–812, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. V. Chevaleyre and P. E. Castillo, “Endocannabinoid-mediated metaplasticity in the hippocampus,” Neuron, vol. 43, no. 6, pp. 871–881, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. I. Katona and T. F. Freund, “Endocannabinoid signaling as a synaptic circuit breaker in neurological disease,” Nature Medicine, vol. 14, no. 9, pp. 923–930, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. I. Soltesz, B. E. Alger, M. Kano et al., “Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy,” Nature Reviews Neuroscience, vol. 16, no. 5, pp. 264–277, 2015. View at Publisher · View at Google Scholar
  94. Z. Maglóczky, K. Tóth, R. Karlócai et al., “Dynamic changes of CB1-receptor expression in hippocampi of epileptic mice and humans,” Epilepsia, vol. 51, no. 3, pp. 115–120, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. M. R. Karlócai, K. Tóth, M. Watanabe et al., “Redistribution of CB1 cannabinoid receptors in the acute and chronic phases of pilocarpine-induced epilepsy,” PLoS ONE, vol. 6, no. 11, Article ID e27196, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. Y. Kawamura, M. Fukaya, T. Maejima et al., “The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum,” The Journal of Neuroscience, vol. 26, no. 11, pp. 2991–3001, 2006. View at Publisher · View at Google Scholar · View at Scopus
  97. M. J. Wallace, J. L. Wiley, B. R. Martin, and R. J. DeLorenzo, “Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects,” European Journal of Pharmacology, vol. 428, no. 1, pp. 51–57, 2001. View at Publisher · View at Google Scholar · View at Scopus
  98. R. L. Kow, K. Jiang, A. V. Naydenov, J. H. Le, N. Stella, and N. M. Nathanson, “Modulation of pilocarpine-induced seizures by cannabinoid receptor 1,” PLoS ONE, vol. 9, no. 4, Article ID e95922, 2014. View at Publisher · View at Google Scholar · View at Scopus
  99. A. V. Naydenov, E. A. Horne, C. S. Cheah et al., “ABHD6 blockade exerts antiepileptic activity in PTZ-induced seizures and in spontaneous seizures in R6/2 mice,” Neuron, vol. 83, no. 2, pp. 361–371, 2014. View at Publisher · View at Google Scholar · View at Scopus
  100. G. Marsicano, S. Goodenough, K. Monory et al., “CB1 cannabinoid receptors and on-demand defense against excitotoxicity,” Science, vol. 302, no. 5642, pp. 84–88, 2003. View at Publisher · View at Google Scholar · View at Scopus
  101. M. D. Bhaskaran and B. N. Smith, “Cannabinoid-mediated inhibition of recurrent excitatory circuitry in the dentate gyrus in a mouse model of temporal lobe epilepsy,” PLoS ONE, vol. 5, no. 5, Article ID e10683, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. E. von Rüden, R. Bogdanovic, C. Wotjak, and H. Potschka, “Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice,” Neurobiology of Disease, vol. 77, pp. 238–245, 2015. View at Publisher · View at Google Scholar
  103. J. Yu, A. Proddutur, B. Swietek, F. S. Elgammal, and V. Santhakumar, “Functional reduction in cannabinoid-sensitive heterotypic inhibition of dentate basket cells in epilepsy: impact on network rhythms,” Cerebral Cortex, 2015. View at Publisher · View at Google Scholar
  104. L. M. Dibbens, H.-J. Feng, M. C. Richards et al., “GABRD encoding a protein for extra- or peri-synaptic GABAA receptors is a susceptibility locus for generalized epilepsies,” Human Molecular Genetics, vol. 13, no. 13, pp. 1315–1319, 2004. View at Publisher · View at Google Scholar · View at Scopus
  105. E. Eugène, C. Depienne, S. Baulac et al., “GABAA receptor γ2 subunit mutations linked to human epileptic syndromes differentially affect phasic and tonic inhibition,” Journal of Neuroscience, vol. 27, no. 51, pp. 14108–14116, 2007. View at Publisher · View at Google Scholar · View at Scopus
  106. A. Schousboe, K. K. Madsen, M. L. Barker-Haliski, and H. S. White, “The GABA synapse as a target for antiepileptic drugs: a historical overview focused on GABA transporters,” Neurochemical Research, vol. 39, no. 10, pp. 1980–1987, 2014. View at Publisher · View at Google Scholar · View at Scopus
  107. M. M. Durkin, K. E. Smith, L. A. Borden, R. L. Weinshank, T. A. Branchek, and E. L. Gustafson, “Localization of messenger RNAs encoding three GABA transporters in rat brain: an in situ hybridization study,” Molecular Brain Research, vol. 33, no. 1, pp. 7–21, 1995. View at Publisher · View at Google Scholar · View at Scopus
  108. Y. Zhou and N. C. Danbolt, “GABA and glutamate transporters in brain,” Frontiers in Endocrinology, vol. 4, article 165, 2013. View at Publisher · View at Google Scholar
  109. S. Sharopov, R. Chen, H. Sun et al., “Inhibition of different GABA transporter systems is required to attenuate epileptiform activity in the CA3 region of the immature rat hippocampus,” Epilepsy Research, vol. 108, no. 2, pp. 182–189, 2014. View at Publisher · View at Google Scholar · View at Scopus
  110. N. O. Dalby, “Inhibition of γ-aminobutyric acid uptake: anatomy, physiology and effects against epileptic seizures,” European Journal of Pharmacology, vol. 479, no. 1–3, pp. 127–137, 2003. View at Publisher · View at Google Scholar · View at Scopus
  111. N. O. Dalby, C. Thomsen, A. Fink-Jensen et al., “Anticonvulsant properties of two GABA uptake inhibitors NNC 05-2045 and NNC 05-2090, not acting preferentially on GAT-1,” Epilepsy Research, vol. 28, no. 1, pp. 51–61, 1997. View at Publisher · View at Google Scholar · View at Scopus
  112. F. Kersanté, S. C. S. Rowley, I. Pavlov et al., “A functional role for both γ-aminobutyric acid (GABA) transporter-1 and GABA transporter-3 in the modulation of extracellular GABA and GABAergic tonic conductances in the rat hippocampus,” Journal of Physiology, vol. 591, no. 10, pp. 2429–2441, 2013. View at Publisher · View at Google Scholar · View at Scopus
  113. B.-E. Yoon and C. J. Lee, “GABA as a rising gliotransmitter,” Frontiers in Neural Circuits, vol. 8, article 141, 2014. View at Publisher · View at Google Scholar · View at Scopus
  114. Y. Ben-Ari, “Excitatory actions of GABA during development: the nature of the nurture,” Nature Reviews Neuroscience, vol. 3, no. 9, pp. 728–739, 2002. View at Publisher · View at Google Scholar · View at Scopus
  115. K. T. Kahle, T. Z. Deeb, M. Puskarjov et al., “Modulation of neuronal activity by phosphorylation of the K-Cl cotransporter KCC2,” Trends in Neurosciences, vol. 36, no. 12, pp. 726–737, 2013. View at Publisher · View at Google Scholar · View at Scopus
  116. K. T. Kahle, K. J. Staley, B. V. Nahed et al., “Roles of the cation-chloride cotransporters in neurological disease,” Nature Clinical Practice Neurology, vol. 4, no. 9, pp. 490–503, 2008. View at Publisher · View at Google Scholar · View at Scopus
  117. K. Kaila, E. Ruusuvuori, P. Seja, J. Voipio, and M. Puskarjov, “GABA actions and ionic plasticity in epilepsy,” Current Opinion in Neurobiology, vol. 26, pp. 34–41, 2014. View at Publisher · View at Google Scholar · View at Scopus
  118. M. Puskarjov, F. Ahmad, K. Kaila, and P. Blaesse, “Activity-dependent cleavage of the K-Cl cotransporter KCC2 mediated by calcium-activated protease calpain,” The Journal of Neuroscience, vol. 32, no. 33, pp. 11356–11364, 2012. View at Publisher · View at Google Scholar · View at Scopus
  119. N. G. Bowery, “Metabotropic GABA(B) receptors cloned at last,” Trends in Pharmacological Sciences, vol. 18, no. 4, 1997. View at Publisher · View at Google Scholar · View at Scopus
  120. J.-L. Gaiarsa, N. Kuczewski, and C. Porcher, “Contribution of metabotropic GABAB receptors to neuronal network construction,” Pharmacology & Therapeutics, vol. 132, no. 2, pp. 170–179, 2011. View at Publisher · View at Google Scholar
  121. J. R. Chalifoux and A. G. Carter, “GABAB receptor modulation of synaptic function,” Current Opinion in Neurobiology, vol. 21, no. 2, pp. 339–344, 2011. View at Publisher · View at Google Scholar · View at Scopus
  122. B. H. Gähwiler and D. A. Brown, “GABAB-receptor-activated K+ current in voltage-clamped CA3 pyramidal cells in hippocampal cultures,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 5, pp. 1558–1562, 1985. View at Publisher · View at Google Scholar
  123. K. P. Scholz and R. J. Miller, “GABAB receptor-mediated inhibition of Ca2+ currents and synaptic transmission in cultured rat hippocampal neurons,” The Journal of Physiology, vol. 444, pp. 669–686, 1991. View at Publisher · View at Google Scholar
  124. I. M. Mintz and B. P. Bean, “GABAB receptor inhibition of P-type Ca2+ channels in central neurons,” Neuron, vol. 10, no. 5, pp. 889–898, 1993. View at Publisher · View at Google Scholar · View at Scopus
  125. E. O. Mann, M. M. Kohl, and O. Paulsen, “Distinct roles of GABAA and GABAB receptors in balancing and terminating persistent cortical activity,” Journal of Neuroscience, vol. 29, no. 23, pp. 7513–7518, 2009. View at Publisher · View at Google Scholar · View at Scopus
  126. M. Vergnes, A. Boehrer, S. Simler, R. Bernasconi, and C. Marescaux, “Opposite effects of GABAB receptor antagonists on absences and convulsive seizures,” European Journal of Pharmacology, vol. 332, no. 3, pp. 245–255, 1997. View at Publisher · View at Google Scholar · View at Scopus
  127. H. M. Prosser, C. H. Gill, W. D. Hirst et al., “Epileptogenesis and enhanced prepulse inhibition in GABAB1-deficient mice,” Molecular and Cellular Neuroscience, vol. 17, no. 6, pp. 1059–1070, 2001. View at Publisher · View at Google Scholar · View at Scopus
  128. V. Schuler, C. Lüscher, C. Blanchet et al., “Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABAB responses in mice lacking GABAB(1),” Neuron, vol. 31, no. 1, pp. 47–58, 2001. View at Publisher · View at Google Scholar · View at Scopus
  129. M. Kofler, M. F. Kronenberg, C. Rifici, L. Saltuari, and G. Bauer, “Epileptic seizures associated with intrathecal baclofen application,” Neurology, vol. 44, no. 1, pp. 25–27, 1994. View at Publisher · View at Google Scholar · View at Scopus
  130. A. P. Princivalle, J. S. Duncan, M. Thom, and N. G. Bowery, “GABAB1a, GABAB1b AND GABAB2 mRNA variants expression in hippocampus resected from patients with temporal lobe epilepsy,” Neuroscience, vol. 122, no. 4, pp. 975–984, 2003. View at Publisher · View at Google Scholar
  131. T. Dugladze, N. Maziashvili, C. Börgers et al., “GABAB autoreceptor-mediated cell type-specific reduction of inhibition in epileptic mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 37, pp. 15073–15078, 2013. View at Publisher · View at Google Scholar · View at Scopus
  132. C. R. Houser, J. E. Miyashiro, B. E. Swartz, G. O. Walsh, J. R. Rieh, and A. V. Delgado-Escueta, “Altered patterns of dynorphin immunoreactivity suggest mossy fiber reorganization in human hippocampal epilepsy,” Journal of Neuroscience, vol. 10, no. 1, pp. 267–282, 1990. View at Google Scholar · View at Scopus
  133. Y. Perez, “Axonal sprouting of CA1 pyramidal cells in hyperexcitable hippocampal slices of kainate-treated rats,” European Journal of Neuroscience, vol. 8, no. 4, pp. 736–748, 1996. View at Publisher · View at Google Scholar · View at Scopus
  134. W. Zhang, R. Yamawaki, X. Wen et al., “Surviving hilar somatostatin interneurons enlarge, sprout axons, and form new synapses with granule cells in a mouse model of temporal lobe epilepsy,” Journal of Neuroscience, vol. 29, no. 45, pp. 14247–14256, 2009. View at Publisher · View at Google Scholar · View at Scopus
  135. Z. Peng, N. Zhang, W. Wei et al., “A reorganized GABAergic circuit in a model of epilepsy: evidence from optogenetic labeling and stimulation of somatostatin interneurons,” Journal of Neuroscience, vol. 33, no. 36, pp. 14392–14405, 2013. View at Publisher · View at Google Scholar · View at Scopus
  136. Y.-Q. Liu, F. Yu, W.-H. Liu, X.-H. He, and B.-W. Peng, “Dysfunction of hippocampal interneurons in epilepsy,” Neuroscience Bulletin, vol. 30, no. 6, pp. 985–998, 2014. View at Publisher · View at Google Scholar · View at Scopus
  137. C. Sun, J. Sun, A. Erisir, and J. Kapur, “Loss of cholecystokinin-containing terminals in temporal lobe epilepsy,” Neurobiology of Disease, vol. 62, pp. 44–55, 2014. View at Publisher · View at Google Scholar · View at Scopus
  138. A. Araque, G. Carmignoto, and P. G. Haydon, “Dynamic signaling between astrocytes and neurons,” Annual Review of Physiology, vol. 63, pp. 795–813, 2001. View at Publisher · View at Google Scholar · View at Scopus
  139. M. K. Shelton and K. D. McCarthy, “Mature hippocampal astrocytes exhibit functional metabotropic and ionotropic glutamate receptors in situ,” Glia, vol. 26, no. 1, pp. 1–11, 1999. View at Publisher · View at Google Scholar · View at Scopus
  140. J. T. Porter and K. D. McCarthy, “Hippocampal astrocytes in situ respond to glutamate released from synaptic terminals,” Journal of Neuroscience, vol. 16, no. 16, pp. 5073–5081, 1996. View at Google Scholar · View at Scopus
  141. A. Araque, E. D. Martín, G. Perea, J. I. Arellano, and W. Buño, “Synaptically released acetylcholine evokes Ca2+ elevations in astrocytes in hippocampal slices,” Journal of Neuroscience, vol. 22, no. 7, pp. 2443–2450, 2002. View at Google Scholar · View at Scopus
  142. T. Eid, J. Hammer, E. Rundén-Pran et al., “Increased expression of phosphate-activated glutaminase in hippocampal neurons in human mesial temporal lobe epilepsy,” Acta Neuropathologica, vol. 113, no. 2, pp. 137–152, 2007. View at Publisher · View at Google Scholar · View at Scopus
  143. J. Wetherington, G. Serrano, and R. Dingledine, “Astrocytes in the epileptic brain,” Neuron, vol. 58, no. 2, pp. 168–178, 2008. View at Publisher · View at Google Scholar · View at Scopus
  144. M. Gómez-Gonzalo, G. Losi, A. Chiavegato et al., “An excitatory loop with astrocytes contributes to drive neurons to seizure threshold,” PLoS Biology, vol. 8, no. 4, 2010. View at Publisher · View at Google Scholar · View at Scopus
  145. O. Pascual, S. Ben Achour, P. Rostaing, A. Triller, and A. Bessis, “Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 4, pp. E197–E205, 2012. View at Publisher · View at Google Scholar · View at Scopus
  146. F.-R. Tang and W.-L. Lee, “Expression of the group II and III metabotropic glutamate receptors in the hippocampus of patients with mesial temporal lobe epilepsy,” Journal of Neurocytology, vol. 30, no. 2, pp. 137–143, 2001. View at Publisher · View at Google Scholar · View at Scopus
  147. N. C. de Lanerolle, T. Eid, G. von Campe, I. Kovacs, D. D. Spencer, and M. Brines, “Glutamate receptor subunits GluR1 and GluR2/3 distribution shows reorganization in the human epileptogenic hippocampus,” European Journal of Neuroscience, vol. 10, no. 5, pp. 1687–1703, 1998. View at Publisher · View at Google Scholar
  148. C. Steinhäuser and G. Seifert, “Glial membrane channels and receptors in epilepsy: impact for generation and spread of seizure activity,” European Journal of Pharmacology, vol. 447, no. 2-3, pp. 227–237, 2002. View at Publisher · View at Google Scholar · View at Scopus
  149. R. Y. Nagaraja, G. Grecksch, K. G. Reymann, H. Schroeder, and A. Becker, “Group I metabotropic glutamate receptors interfere in different ways with pentylenetetrazole seizures, kindling, and kindling-related learning deficits,” Naunyn-Schmiedeberg’s Archives of Pharmacology, vol. 370, no. 1, pp. 26–34, 2004. View at Google Scholar · View at Scopus
  150. R. Y. Nagaraja, A. Becker, K. G. Reymann, and D. Balschun, “Repeated administration of group I mGluR antagonists prevents seizure-induced long-term aberrations in hippocampal synaptic plasticity,” Neuropharmacology, vol. 49, supplement 1, pp. 179–187, 2005. View at Publisher · View at Google Scholar · View at Scopus
  151. G. Carmignoto and T. Fellin, “Glutamate release from astrocytes as a non-synaptic mechanism for neuronal synchronization in the hippocampus,” Journal of Physiology Paris, vol. 99, no. 2-3, pp. 98–102, 2006. View at Publisher · View at Google Scholar · View at Scopus
  152. G.-F. Tian, H. Azmi, T. Takano et al., “An astrocytic basis of epilepsy,” Nature Medicine, vol. 11, no. 9, pp. 973–981, 2005. View at Publisher · View at Google Scholar · View at Scopus
  153. T. Fellin, M. Gomez-Gonzalo, S. Gobbo, G. Carmignoto, and P. G. Haydon, “Astrocytic glutamate is not necessary for the generation of epileptiform neuronal activity in hippocampal slices,” Journal of Neuroscience, vol. 26, no. 36, pp. 9312–9322, 2006. View at Publisher · View at Google Scholar · View at Scopus
  154. M. C. Angulo, A. S. Kozlov, S. Charpak, and E. Audinat, “Glutamate released from glial cells synchronizes neuronal activity in the hippocampus,” Journal of Neuroscience, vol. 24, no. 31, pp. 6920–6927, 2004. View at Publisher · View at Google Scholar · View at Scopus
  155. V. Crunelli and G. Carmignoto, “New vistas on astroglia in convulsive and non-convulsive epilepsy highlight novel astrocytic targets for treatment,” Journal of Physiology, vol. 591, no. 4, pp. 775–785, 2013. View at Publisher · View at Google Scholar · View at Scopus
  156. M. Navarrete and A. Araque, “Endocannabinoids mediate neuron-astrocyte communication,” Neuron, vol. 57, no. 6, pp. 883–893, 2008. View at Publisher · View at Google Scholar · View at Scopus
  157. M. E. Hofmann and C. J. Frazier, “Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention,” Experimental Neurology, vol. 244, pp. 43–50, 2013. View at Publisher · View at Google Scholar · View at Scopus
  158. G. Coiret, J. Ster, B. Grewe et al., “Neuron to astrocyte communication via cannabinoid receptors is necessary for sustained epileptiform activity in rat hippocampus,” PLoS ONE, vol. 7, no. 5, Article ID e37320, 2012. View at Publisher · View at Google Scholar · View at Scopus
  159. L. Mariotti, G. Losi, M. Sessolo, I. Marcon, and G. Carmignoto, “The inhibitory neurotransmitter GABA evokes long-lasting Ca2+ oscillations in cortical astrocytes,” Glia, vol. 64, no. 3, pp. 363–373, 2016. View at Publisher · View at Google Scholar
  160. J. Kang, L. Jiang, S. A. Goldman, and M. Nedergaard, “Astrocyte-mediated potentiation of inhibitory synaptic transmission,” Nature Neuroscience, vol. 1, no. 8, pp. 683–692, 1998. View at Publisher · View at Google Scholar · View at Scopus
  161. Q. Liu, Q. Xu, J. Kang, and M. Nedergaard, “Astrocyte activation of presynaptic metabotropic glutamate receptors modulates hippocampal inhibitory synaptic transmission,” Neuron Glia Biology, vol. 1, no. 4, pp. 307–316, 2004. View at Publisher · View at Google Scholar
  162. A. Semyanov and D. M. Kullmann, “Modulation of GABAergic signaling among interneurons by metabotropic glutamate receptors,” Neuron, vol. 25, no. 3, pp. 663–672, 2000. View at Publisher · View at Google Scholar · View at Scopus
  163. P. Somogyi, Y. Dalezios, R. Luján, J. D. B. Roberts, M. Watanabe, and R. Shigemoto, “High level of mGluR7 in the presynaptic active zones of select populations of GABAergic terminals innervating interneurons in the rat hippocampus,” European Journal of Neuroscience, vol. 17, no. 12, pp. 2503–2520, 2003. View at Publisher · View at Google Scholar · View at Scopus
  164. N. Kogo, Y. Dalezios, M. Capogna, F. Ferraguti, R. Shigemoto, and P. Somogyi, “Depression of GABAergic input to identified hippocampal neurons by group III metabotropic glutamate receptors in the rat,” European Journal of Neuroscience, vol. 19, no. 10, pp. 2727–2740, 2004. View at Publisher · View at Google Scholar · View at Scopus
  165. A. Jouvenceau, P. Dutar, and J.-M. Billard, “Presynaptic depression of inhibitory postsynaptic potentials by metabotropic glutamate receptors in rat hippocampal CA1 pyramidal cells,” European Journal of Pharmacology, vol. 281, no. 2, pp. 131–139, 1995. View at Publisher · View at Google Scholar · View at Scopus
  166. U. Lalo, O. Palygin, S. Rasooli-Nejad, J. Andrew, P. G. Haydon, and Y. Pankratov, “Exocytosis of ATP from astrocytes modulates phasic and tonic inhibition in the neocortex,” PLoS Biology, vol. 12, no. 1, Article ID e1001747, 2014, Erratum in: PLoS Biology, vol. 12, no. 4, Article ID e1001857, 2014. View at Publisher · View at Google Scholar